Results 161 to 170 of about 7,402 (202)
Some of the next articles are maybe not open access.
Cobicistat, a pharmacoenhancer for HIV treatments
Drugs of Today, 2013Cobicistat is a novel cytochrome P450 3A4 (CYP3A4) inhibitor in advanced clinical evaluation for use as a pharmacoenhancer of antiretroviral drugs. It lacks significant anti-HIV activity and is more selective than ritonavir in its enzyme inhibition. In addition, its water solubility may lend itself to coformulation with other drugs.
openaire +2 more sources
Elvitegravir/cobicistat, mirabegron, and linaclotide
Journal of the American Pharmacists Association, 2012Daniel A, Hussar, Loren N, Martinez
openaire +2 more sources